Home › Funds › NWI MANAGEMENT LP › NAMS

NWI MANAGEMENT LP position in NAMS

NEWAMSTERDAM PHARMA COMPANY · Health Care

NWI MANAGEMENT LP reported holding 702,000 shares of NAMS (NEWAMSTERDAM PHARMA COMPANY) in its Q3 2026 13F filing — a position valued at US$17.1M, representing 0.76% of its reported portfolio and ranking #28 among its reported holdings. NWI MANAGEMENT LP has disclosed NAMS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)702.00K sh
Reported value held$17.07M
Portfolio Weight0.76%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How NWI MANAGEMENT LP's NAMS position evolved

NWI MANAGEMENT LP first disclosed a stake in NAMS in Q4 2025 at 702,000 shares (US$24.6M). Across 4 filings, NWI MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 702,000 shares valued at US$17.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 702.00K $24.63M New
Q1 2026 702.00K $22.47M Hold
Q2 2026 702.00K $23.79M Hold
Q3 2026 702.00K $17.07M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAMS and 13F data

NAMS (NEWAMSTERDAM PHARMA COMPANY) is a Health Care company. 41 other funds we track also report a position in NAMS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$613.0M), RA CAPITAL MANAGEMENT, L.P. (US$323.7M), FCPM III SERVICES B.V. (US$287.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAMS

All NAMS fund holders →

FAQ

How long has NWI MANAGEMENT LP held NAMS?

NWI MANAGEMENT LP has disclosed NAMS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NWI MANAGEMENT LP's current position in NAMS?

As of Q3 2026, NWI MANAGEMENT LP holds 702.00K shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), valued at $17.07M, representing 0.76% of its reported portfolio and ranking #28.

Has NWI MANAGEMENT LP been buying or selling NAMS?

In the latest 13F filing (Q3 2026), NWI MANAGEMENT LP held unchanged its position in NAMS.

Which other funds hold NAMS?

Other major institutional holders of NAMS include Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.